Skip to main content
Caplight Logo









OncoPrecision

OncoPrecision

Private
ArgentinaHealthcare & Life Scienceshttps://oncoprecision.bio/

Last Round

Seed

Apr 1, 2022

Total Funding Raised

$5M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

OncoPrecision is a biotechnology company that develops a patient micro-avatar platform leveraging single-cell high-throughput biology and machine learning to tailor cancer therapy.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

antibody-drug conjugateADCprecision medicinetargeted cancer therapymonocytic leukemiadrug discoverybiotechCD64 targetingAI-enhanced discoverypatient micro-avatarshematologic malignanciespersonalized oncologydrug resistance testingclinical trialbiopharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OncoPrecision Comparables

Compare OncoPrecision with similar companies based on industry and business-model similarity.

OncoPrecision comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Solu Therapeutics
78%
Pfizer
67%
AbbVie
65%

OncoPrecision Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 1, 2022
Pre SeedFeb 16, 2021

Key People

Founding team and executive leadership

Gastón Soria

Co-Founder Chief Scientific Officer

Founding Team

Tarek Ali Zaki

Co-Founder & CEO

Founding Team

OncoPrecision Investors

Notable investors and investment history

OncoPrecision investors
InvestorRounds
Creative VenturesSeed
GRIDXSeed, Pre Seed
IndieBioPre Seed
New York VenturesSeed
SOSVSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 89% MoM.

  • Dec 1, 2025

    Will attend and present at the 67th ASH Annual Meeting.

OncoPrecision Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OncoPrecision Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OncoPrecision's valuation, stock price, and market status.

Firmographic Details

HeadquartersArgentina
Employee Range16
Year Founded2020
Last FundingApr 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?